Kansas City, KSNCT04530383Now EnrollingIRB Ready

Cystic Fibrosis-related Diabetes Clinical Trial in Kansas City, KS

Access cutting-edge cystic fibrosis-related diabetes treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.

Sponsored by University of Kansas Medical Center

Quick Self-Assessment

See if you qualify for this Kansas City location

Preparing your pre-screening questions…

Expert Care in Kansas City

Access cystic fibrosis-related diabetes specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cystic fibrosis-related diabetes treatment provided free

Apply for This Kansas City Location

Check if you qualify for this cystic fibrosis-related diabetes clinical trial in Kansas City, KS

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Kansas City

    Convenient for KS residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Kansas City site if eligible
  4. 4Begin participation

About This Cystic Fibrosis-related Diabetes Study in Kansas City

The purpose of this study is to assess the efficacy of metformin to improve airway ion channel function in those with CF-related diabetes (CFRD)

Sponsor: University of Kansas Medical Center

Who Can Participate

Inclusion Criteria

Age \>18 years with a prior diagnosis of CF.
Use of ivacaftor or elexacaftor/tezacaftor/ivacaftor or vanzacaftor/tezacaftor/deutivacaftor for 30 days prior to day 0
Diagnosis of CFRD with evidence of continued glucose intolerance at least 6 months after starting qualifying modulator therapy will be based upon one of the following:
Insulin use
Hemoglobin A1C \>6.5%
Fasting glucose \>126 mg/dl
Non-fasting glucose \>200 mg/dl (random or as part of a 2-hr OGTT)

Exclusion Criteria

Prior lung or liver transplant
Use of supplemental oxygen
CF pulmonary exacerbation requiring hospitalization or intravenous antibiotics in the preceding 30 days
Systemic corticosteroid or regular non-steroidal anti-inflammatory use in the preceding 30 days
Cardiac, renal (creatinine clearance \<45 mL/minute), neurologic, psychiatric, endocrine or neoplastic diseases that are judged to interfere with participation in the study
Alanine aminotransferase, aspartate aminotransferase or alkaline phosphatase \>1.5X the upper limit of normal; bilirubin \>3 mg/dL
Taking medications that interact with metformin.
Vitamin B12 deficiency
Pregnancy or lactation
Inability or unwillingness to comply with an approved contraceptive method during the study period (females of childbearing age)
Use of medications known to be strong CYP inducers or moderate to strong CYP inhibitors
In the opinion of the investigator any severe or acute or chronic condition or laboratory abnormality that may increase the risk associated with trial participation or make the subject inappropriate for enrollment
Participation in another interventional trial that, in the opinion of the investigator, has the potential to affect the primary outcome

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Kansas City?

Yes, this clinical trial (NCT04530383) has an active research site in Kansas City, KS that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cystic Fibrosis-related Diabetes Treatment Options in Kansas City, KS

If you're searching for cystic fibrosis-related diabetes treatment options in Kansas City, KS, this clinical trial (NCT04530383) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cystic fibrosis-related diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cystic fibrosis-related diabetes clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Kansas City, KS

See all essential tremor clinical trials recruiting in Kansas City — not just this study.

Browse Essential Tremor Trials in Kansas City →

Browse More Trials by Condition

Essential Tremor TrialsCystic Fibrosis TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsFibromyalgia TrialsAll Conditions →

Ready to Join in Kansas City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Kansas City, KS